Background Patients with cancer may be at high risk of adverse outcomes from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …

PURPOSE SARS-CoV-2 (COVID-19) is a systemic infection. Patients with cancer are
immunocompromised and may be vulnerable to COVID-related morbidity and mortality. The …

PURPOSE Coronavirus-2019 (COVID-19) mortality is higher in patients with cancer than in
the general population, yet the cancer-associated risk factors for COVID-19 adverse …

PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …

Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …

Background Cancer patients with coronavirus disease 2019 (COVID-19) have been
reported to have double the case fatality rate of the general population. Methods A …

Background Concerns have emerged about the higher risk of fatal coronavirus disease
2019 (COVID-19) in cancer patients. In this article, we review the experience of a …

Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …

Background COVID-19 has spread globally. Epidemiological susceptibility to COVID-19 has
been reported in patients with cancer. We aimed to systematically characterise clinical …

Background The medium-term and long-term impact of COVID-19 in patients with cancer is
not yet known. In this study, we aimed to describe the prevalence of COVID-19 sequelae …